ABRA anticorps (AA 13-381) (FITC)
Aperçu rapide pour ABRA anticorps (AA 13-381) (FITC) (ABIN7965643)
Antigène
Voir toutes ABRA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 13-381
-
Fonction
- Anti-ABRA Antibody FITC Conjugated
-
Réactivité croisée (Details)
- No cross-reactivity with other proteins.
-
Purification
- Immunogen affinity purified.
-
Immunogène
- E.coli-derived human ABRA recombinant protein (Position: A13-K381).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Date de péremption
- 12 months
-
-
- ABRA (Actin-Binding rho Activating Protein (ABRA))
-
Autre désignation
- ABRA
-
Sujet
-
Background: Predicted to enable actin binding activity. Predicted to be involved in positive regulation of DNA-binding transcription factor activity, positive regulation of Rho protein signal transduction, and positive regulation of transcription by RNA polymerase II. Predicted to act upstream of or within positive regulation of transcription, DNA-templated and protein import into nucleus. Located in plasma membrane.
Gene Full Name: actin binding Rho activating protein
-
ID gène
- 137735
-
UniProt
- Q8N0Z2
-
Pathways
- Protein targeting to Nucleus
Antigène
-